01—Abstract
Summary
Summary of the 10-K filed December 24, 1998. Cited figures are marked; the original filing is the authoritative source.
Gartner Group, Inc. (now Gartner) reported fiscal 1998 (year ended September 30, 1998) total revenues of $642.0 milliona, up 26% from $511.2 million in fiscal 1997.
Advisory and measurement revenue rose 25% to $494.7 millionb, learning revenue fell 15% to $18.1 million following the sale of GartnerLearning on September 1, 1998, and other revenue (principally consulting and conferences) rose 38% to $129.2 million. Operating income increased 23% to $143.5 million, and net income was $88.3 million, or $0.84 per diluted share, versus $0.71 in fiscal 1997. Excluding acquisition-related and nonrecurring charges, operating income rose 29% to $150.8 million.
Contract value increased 18% to approximately $596.7 millionc at September 30, 1998. The balance sheet strengthened, with cash, cash equivalents and marketable securities of $262.3 million and stockholders' equity of $414.9 million at year end. Cash provided by operating activities was $97.8 million.
Renewal activity remained high, with approximately 85%d of clients having renewed one or more services in the last twelve months, though the filing cautions that this rate is not necessarily indicative of revenue retention. The most significant item for investors is a proposed recapitalization approved in principle on November 12, 1998, with IMS Health Inc., which owns 47.6 million shares (47%) of Class A Common Stock.
The plan includes a new Class B Common Stock entitled to elect at least 80% of the board, a one-time special cash dividend of $300.0 million, and a $300.0 million share repurchase after the spin-off. These actions are expected to be completed in the third quarter of fiscal 1999, subject to IRS approval and non-IMS Health shareholder approval.
02—Key points
Key Highlights
- Total revenues rose 26% to $642.0 million in fiscal 1998, led by a 25% increase in advisory and measurement revenue to $494.7 million.
- Operating income increased 23% to $143.5 million; excluding acquisition-related and nonrecurring charges, it rose 29% to $150.8 million.
- Diluted net income per share was $0.84 versus $0.71 in fiscal 1997; excluding certain charges and the GartnerLearning sale loss, diluted EPS was $0.93, a 31% increase.
- Contract value increased 18% to approximately $596.7 million at September 30, 1998, and approximately 85% of clients renewed one or more services in the last twelve months.
- Cash, cash equivalents and marketable securities totaled $262.3 million at September 30, 1998, up $73.5 million from the prior year.
- GartnerLearning was sold on September 1, 1998 to a subsidiary of Harcourt Brace & Company for $5.0 million in cash and an 8% equity interest in Netg, with a put option for $48.0 million, resulting in a pre-tax loss of approximately $2.0 million.
- A proposed recapitalization with IMS Health includes a $300.0 million special cash dividend and a $300.0 million share repurchase, with Class B stock electing at least 80% of the board, expected to close in the third quarter of fiscal 1999.
03—Questions
Frequently Asked Questions
What drove revenue growth in fiscal 1998?
Total revenues rose 26% to $642.0 million. Advisory and measurement revenue increased 25% to $494.7 million, reflecting new product acceptance, sales penetration into new and existing clients, and acquisitions. Other revenue, principally consulting and conferences, increased 38% to $129.2 million, attributed mainly to the Symposia and ITxpo events and new events and acquired businesses.
How did the GartnerLearning sale affect results?
GartnerLearning was sold on September 1, 1998 for $5.0 million in cash and an 8% equity interest in Netg, with a put option for $48.0 million exercisable for two years beginning September 1, 2002 if certain conditions are met. The pre-tax loss on sale was approximately $2.0 million, and learning revenue fell 15% to $18.1 million. The sale also added $4.2 million in taxes, primarily due to the reversal of non-deductible goodwill.
What is the proposed IMS Health recapitalization?
On November 12, 1998, the Board approved an agreement in principle with IMS Health, which owns 47.6 million shares (47%) of Class A Common Stock. IMS Health will exchange 40.7 million shares for new Class B Common Stock, which will elect at least 80% of the board and be distributed to IMS Health shareholders in a tax-free spin-off. The company will pay a $300.0 million special cash dividend to shareholders of record before the spin-off and repurchase $300.0 million of Class A stock afterward. Completion is expected in the third quarter of fiscal 1999, subject to IRS approval and non-IMS Health shareholder approval.
How much did the company spend on acquisitions and capital investments in fiscal 1998?
The company used $47.5 million in cash for acquisitions, including Vision Events International for $20.5 million, Interpose for $7.5 million, and The Research Board for $6.4 million. It also invested $15.0 million in unconsolidated businesses and spent $24.3 million on capital assets. Cash used for investing activities totaled $145.2 million, including net purchases of marketable securities of $58.2 million.
What are the key risks cited in the filing?
The filing cites intense competition from independent providers, internal planning organizations of clients, and indirect competitors such as media companies and consulting firms, with few barriers to entry. It notes that the business depends on retaining qualified IT analysts, faces risks from international operations including exchange rates and taxation, and states that renewal rates may not continue. Year 2000 remediation involves significant supply chain uncertainty, and the company identified $1.9 million in Year 2000 expenses in fiscal 1998 with $5.2 million forecast for fiscal 1999.
04—Continue